298 related articles for article (PubMed ID: 36064539)
1. Treatment patterns and cost of exacerbations in patients with chronic obstructive pulmonary disease using multiple inhaler triple therapy in South Korea.
Lee CH; Kim MS; Yeo SH; Rhee CK; Park HW; Yang BR; Lee J; Cho EY; Xu X; Navarro Rojas AA; Shantakumar S; Milea D; Choi NK
Respir Res; 2022 Sep; 23(1):231. PubMed ID: 36064539
[TBL] [Abstract][Full Text] [Related]
2. Medication adherence and persistence in chronic obstructive pulmonary disease patients receiving triple therapy in a USA commercially insured population.
Bogart M; Stanford RH; Laliberté F; Germain G; Wu JW; Duh MS
Int J Chron Obstruct Pulmon Dis; 2019; 14():343-352. PubMed ID: 30863037
[TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics, Treatment Persistence, and Outcomes Among Patients With COPD Treated With Single- or Multiple-Inhaler Triple Therapy: A Retrospective Analysis in Spain.
Alcázar-Navarrete B; Jamart L; Sánchez-Covisa J; Juárez M; Graefenhain R; Sicras-Mainar A
Chest; 2022 Nov; 162(5):1017-1029. PubMed ID: 35787391
[TBL] [Abstract][Full Text] [Related]
4. A Real-World Analysis of Treatment Patterns and Clinical Characteristics Among Patients with COPD Who Initiated Multiple-Inhaler Triple Therapy in New Zealand.
Xu X; Milea D; Navarro Rojas AA; Braganza A; Holbrook T; Marett B; Young R; Scott RJ; Gribben B
Int J Chron Obstruct Pulmon Dis; 2021; 16():1835-1850. PubMed ID: 34177262
[TBL] [Abstract][Full Text] [Related]
5. Economic impact of delaying initiation with multiple-inhaler maintenance triple therapy in Spanish patients with chronic obstructive pulmonary disease.
Sicras Mainar A; Huerta A; Navarro Artieda R; Monsó E; Landis SH; Ismaila AS
Int J Chron Obstruct Pulmon Dis; 2019; 14():2121-2129. PubMed ID: 31571848
[TBL] [Abstract][Full Text] [Related]
6. Real-World Treatment Patterns of Multiple-Inhaler Triple Therapy Among Patients with Chronic Obstructive Pulmonary Disease in UK General Practice.
Sansbury LB; Bains C; Lipson DA; Ismaila AS; Landis SH
Int J Chron Obstruct Pulmon Dis; 2021; 16():1255-1264. PubMed ID: 33986594
[TBL] [Abstract][Full Text] [Related]
7. Adherence and persistence to once-daily single-inhaler versus multiple-inhaler triple therapy among patients with chronic obstructive pulmonary disease in the USA: A real-world study.
Mannino D; Bogart M; Wu B; Germain G; Laliberté F; MacKnight SD; Jung Y; Stiegler M; Duh MS
Respir Med; 2022 Jun; 197():106807. PubMed ID: 35429764
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of New Users of Single- and Multiple-Inhaler Triple Therapy for COPD in Primary Care in England.
Rothnie KJ; Joksaite S; Sansbury LB; Compton C; Di Boscio V; Ismaila AS
Int J Chron Obstruct Pulmon Dis; 2022; 17():1455-1466. PubMed ID: 35769225
[TBL] [Abstract][Full Text] [Related]
9. Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting.
Halpin DMG; Rothnie KJ; Banks V; Czira A; Compton C; Wood R; Tritton T; Massey O; Wild R; Snowise N; Nikitin K; Sharma R; Ismaila AS; Vogelmeier CF
Int J Chron Obstruct Pulmon Dis; 2022; 17():2417-2429. PubMed ID: 36185170
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and medication patterns in patients with COPD prior to initiation of triple therapy with ICS/LAMA/LABA: A retrospective study.
Bogart M; Stanford RH; Reinsch T; Hull M; Buikema A; Hulbert E
Respir Med; 2018 Sep; 142():73-80. PubMed ID: 30170806
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and healthcare resource utilization in patients with chronic obstructive pulmonary disease in Hong Kong.
Ko FWS; Xu X; Chau C; Navarro A; Hui DSC; Milea D
Respir Med; 2024 Feb; 222():107516. PubMed ID: 38184091
[TBL] [Abstract][Full Text] [Related]
12. Disease Burden and Healthcare Utilization Among Patients with Chronic Obstructive Pulmonary Disease (COPD) in England.
Sansbury LB; Lipson DA; Bains C; Anley GA; Rothnie KJ; Ismaila AS
Int J Chron Obstruct Pulmon Dis; 2022; 17():415-426. PubMed ID: 35264848
[TBL] [Abstract][Full Text] [Related]
13. Quantifying the Economic Impact of Delayed Multiple-Inhaler Triple Therapy Initiation in Patients with COPD: A Retrospective Cohort Study of Linked Electronic Medical Record and Hospital Administrative Data in England.
Sansbury LB; Wood RP; Anley GA; Nam Y; Ismaila AS
Int J Chron Obstruct Pulmon Dis; 2021; 16():2795-2808. PubMed ID: 34675504
[TBL] [Abstract][Full Text] [Related]
14. Initiation of Triple Therapy with Multiple Inhalers in Chronic Obstructive Pulmonary Disease: An Analysis of Treatment Patterns from a U.S. Retrospective Database Study.
Lane DC; Stemkowski S; Stanford RH; Tao Z
J Manag Care Spec Pharm; 2018 Nov; 24(11):1165-1172. PubMed ID: 30362922
[TBL] [Abstract][Full Text] [Related]
15. Outcomes Following Initiation of Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol versus Multiple-Inhaler Triple Therapy Among Medicare Advantage with Part D Beneficiaries and Those Commercially Enrolled for Health Care Insurance in the United States.
Bogart M; Bengtson LGS; Johnson MG; Bunner SH; Gronroos NN; DiRocco KK
Int J Chron Obstruct Pulmon Dis; 2024; 19():97-110. PubMed ID: 38226396
[TBL] [Abstract][Full Text] [Related]
16. Treatment Patterns, Healthcare Utilization and Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting β
Requena G; Banks V; Czira A; Wood R; Tritton T; Wild R; Compton C; Ismaila AS
Int J Chron Obstruct Pulmon Dis; 2023; 18():231-245. PubMed ID: 36908830
[TBL] [Abstract][Full Text] [Related]
17. Healthcare Resource Utilization, Exacerbations, and Readmissions Among Medicare Patients with Chronic Obstructive Pulmonary Disease After Long-Acting Muscarinic Antagonist Therapy Initiation with Soft Mist versus Dry Powder Inhalers.
Singer D; Bengtson LGS; Elliott C; Buikema AR; Franchino-Elder J
Int J Chron Obstruct Pulmon Dis; 2020; 15():3239-3250. PubMed ID: 33324047
[TBL] [Abstract][Full Text] [Related]
18. A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established on long-acting mono- or combination therapy.
Mapel D; Laliberté F; Roberts MH; Sama SR; Sundaresan D; Pilon D; Lefebvre P; Duh MS; Patel J
Int J Chron Obstruct Pulmon Dis; 2017; 12():1825-1836. PubMed ID: 28684905
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting Muscarinic Antagonist/Long-Acting β
Requena G; Banks V; Czira A; Wood R; Tritton T; Wild R; Compton C; Duarte M; Ismaila AS
Int J Chron Obstruct Pulmon Dis; 2022; 17():1781-1795. PubMed ID: 35983168
[TBL] [Abstract][Full Text] [Related]
20. Treatment Patterns and Disease Burden Associated with Multiple-Inhaler Triple-Therapy Use in Asthma.
Oppenheimer J; Bogart M; Bengtson LGS; White J; Sundquist K; Lima R; Averell C
J Allergy Clin Immunol Pract; 2022 Feb; 10(2):485-494.e5. PubMed ID: 34626859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
